YTHDF2 and gastric cancer: The clinical staging results of GC patients showed that the expression level of YTHDF2 was significantly correlated with clinical analysis, and the expression level of YTHDF2 was lower in the tissues with a higher malignant degree of GC (Figure 1G and Supplementary Figure 1D).